Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
85118793 | 8511879 | 3 | F | 20160628 | 20120413 | 20160811 | PER | US-ASTRAZENECA-2011SE59953 | ASTRAZENECA | 55.00 | YR | F | Y | 68.00000 | KG | 20160811 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
85118793 | 8511879 | 1 | PS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 21153 | 40 | MG | QD | ||||||
85118793 | 8511879 | 2 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 21153 | 40 | MG | QD | ||||||
85118793 | 8511879 | 3 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 21153 | 40 | MG | QD | ||||||
85118793 | 8511879 | 4 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 21153 | 40 | MG | QD | ||||||
85118793 | 8511879 | 5 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 21153 | 40 | MG | QD | ||||||
85118793 | 8511879 | 6 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 21153 | 40 | MG | QD | ||||||
85118793 | 8511879 | 7 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 21153 | 40 | MG | QD | ||||||
85118793 | 8511879 | 8 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 21153 | 40 | MG | QD | ||||||
85118793 | 8511879 | 9 | SS | PRILOSEC OTC | OMEPRAZOLE MAGNESIUM | 1 | Oral | U | 0 | MODIFIED-RELEASE TABLET | |||||||||
85118793 | 8511879 | 10 | C | TOFRANIL | IMIPRAMINE HYDROCHLORIDE | 1 | Oral | 0 | 100 | MG | QD | ||||||||
85118793 | 8511879 | 11 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | Oral | 0 | 10 | MG | QD | ||||||||
85118793 | 8511879 | 12 | C | INDERAL | PROPRANOLOL HYDROCHLORIDE | 1 | Oral | 0 | 10 | MG | QD | ||||||||
85118793 | 8511879 | 13 | C | INDERAL | PROPRANOLOL HYDROCHLORIDE | 1 | Oral | 0 | 10 | MG | QD | ||||||||
85118793 | 8511879 | 14 | C | INDERAL | PROPRANOLOL HYDROCHLORIDE | 1 | Oral | 0 | 10 | MG | QD | ||||||||
85118793 | 8511879 | 15 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 0 | 10 | MG | BID | ||||||||
85118793 | 8511879 | 16 | C | XANAX | ALPRAZOLAM | 1 | Oral | 0 | .025 | MG | TID | ||||||||
85118793 | 8511879 | 17 | C | RANITIDINE. | RANITIDINE | 1 | Oral | 0 | 150 | MG | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
85118793 | 8511879 | 1 | Helicobacter infection |
85118793 | 8511879 | 2 | Gastrooesophageal reflux disease |
85118793 | 8511879 | 3 | Gastric ulcer |
85118793 | 8511879 | 4 | Abdominal discomfort |
85118793 | 8511879 | 5 | Helicobacter infection |
85118793 | 8511879 | 6 | Gastrooesophageal reflux disease |
85118793 | 8511879 | 7 | Gastric ulcer |
85118793 | 8511879 | 8 | Abdominal discomfort |
85118793 | 8511879 | 10 | Depression |
85118793 | 8511879 | 11 | Depression |
85118793 | 8511879 | 12 | Cardiac disorder |
85118793 | 8511879 | 13 | Anxiety |
85118793 | 8511879 | 14 | Depression |
85118793 | 8511879 | 15 | Blood pressure abnormal |
85118793 | 8511879 | 16 | Anxiety |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
85118793 | 8511879 | Abdominal discomfort | |
85118793 | 8511879 | Abdominal pain upper | |
85118793 | 8511879 | Drug dose omission | |
85118793 | 8511879 | Drug ineffective | |
85118793 | 8511879 | Gastric ulcer | |
85118793 | 8511879 | Nausea | |
85118793 | 8511879 | Therapeutic response increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |